Showing results (1-10 of 690) with videos related to
Sort By:
Pageof 69
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Staphylococcal enterotoxin H displays unique MHC class II-binding propertiesH Nilsson, P Björk, M Dohlsten, et al.Journal of Molecular Biology|September 15, 2000
The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR moleculesM Hâkansson, K Petersson, H Nilsson, et al.The Journal of Investigative Dermatology|April 5, 2001
Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation modelW H Boehncke, K Hardt-Weinelt, H Nilsson, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|November 20, 2001
Cooperative zinc binding in a staphylococcal enterotoxin A mutant mimics the SEA-MHC class II interactionM Håkansson, P Antonsson, P Björk, et al.The EMBO Journal|December 16, 1996
The crystal structure of staphylococcal enterotoxin type D reveals Zn2+-mediated homodimerizationM Sundström, L Abrahmsén, P Antonsson, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptorsR Al-Daccak, K Mehindate, F Damdoumi, et al.Infection and Immunity|December 11, 1997
A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivoA Rosendahl, J Hansson, P Antonsson, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1997
Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCRP Antonsson, A G Wingren, J Hansson, et al.The EMBO Journal|July 3, 1995
Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin AL Abrahmsén, M Dohlsten, S Segrén, et al.Cancer Immunology, Immunotherapy : CII|September 1, 1995
Immunotherapy of human colon cancer by antibody-targeted superantigensM Dohlsten, P A Lando, P Björk, et al.Pageof 69